A Phase 2 trial of gemcabene in NASH patients
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Gemcabene (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Acronyms AZURE-1
- 14 Aug 2017 According to a Gemphire Therapeutics media release, top-line results for this study expected in second half of 2018.
- 16 Mar 2017 New trial record
- 15 Mar 2017 According to a Gemphire Therapeutics media release, company plans to initiate this trial in secon half of 2017 and anticipated to complete in the second half of 2018.